Analyst firms · BofA Securities · JNJ

BofA Securities JNJ price target and rating history

Johnson & Johnson (JNJ) · Health Care

BofA Securities rates Johnson & Johnson (JNJ) Neutral with a $166 price target, as of its latest action on Dec 10, 2024. It has published 3 rating actions on JNJ since March 2022, including 0 upgrades and 0 downgrades. Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.

Current rating
Neutral
Price target
$166
Median target, all firms
$263.50
Actions on JNJ
3

BofA Securities price target on JNJ

$185$176$1662023202420252026
BofA Securities price target on JNJ, each point a stated target, March 2022 to December 2024.

Every BofA Securities rating on JNJ

How other firms rate JNJ

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Erste GroupHoldOct 21, 2026
UBSBuy$320Sep 2, 2026
Leerink PartnersOutperform$265May 13, 2026
TD CowenBuy$250Apr 8, 2026
Morgan StanleyOverweight$262Jan 28, 2026

Questions about BofA Securities and JNJ

What is BofA Securities's price target for JNJ?
BofA Securities's latest stated price target for Johnson & Johnson (JNJ) is $166, from its action on Dec 10, 2024.
What is BofA Securities's rating on JNJ?
BofA Securities rates JNJ Neutral, a neutral rating, as of Dec 10, 2024.
When did BofA Securities last change its view on JNJ?
On Dec 10, 2024, BofA Securities resumes coverage at Neutral, price target $166.
How does BofA Securities's JNJ target compare with other analysts?
Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.

More JNJ rating histories

All BofA Securities ratingsJNJ news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.